{"id":10435,"date":"2014-06-25T19:45:17","date_gmt":"2014-06-25T22:45:17","guid":{"rendered":"https:\/\/www.infobioquimica.com\/new\/?p=10435"},"modified":"2016-08-12T20:41:43","modified_gmt":"2016-08-12T23:41:43","slug":"interview-dr-michael-oellerich-germany","status":"publish","type":"post","link":"https:\/\/www.infobioquimica.com\/new\/2014\/06\/25\/interview-dr-michael-oellerich-germany\/","title":{"rendered":"Interview: Dr. Michael Oellerich (Germany)"},"content":{"rendered":"

Michael Oellerich, MD, HonMD, FACB, FAMM, FFPath (RCPI),FRCPath, is a chemical pathologist and a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August University, G\u00f6ttingen, Germany. From 1996 to 1998, he served as Dean of the Faculty of Medicine.<\/p>\n

He was President of WASPaLM, IATDMCT, DGLM, and DGKL. He is Editor-in-Chief of Therapeutic Drug Monitoring<\/em> and was Associate Editor of Clinical Chemistry.<\/em> His research interests include biomarkers in transplantation, proteomics, LC-MS\/MS, and molecular diagnostics. He authored more than 400 publications. He received various awards (e.g. IATDMCT Charles Pippenger Award, WASPaLM Gold-Headed Cane).<\/p>\n

Interview about biomarkers to achieve personalized immunosuppression in transplant recipients.<\/p>\n

Michael Oellerich, MD, HonMD, FACB, FAMM, FFPath (RCPI),FRCPath, is a chemical pathologist and a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August University, G\u00f6ttingen, Germany. From 1996 to 1998, he served as Dean of the Faculty of Medicine. He was President of WASPaLM, IATDMCT, […]<\/p>\n","protected":false},"author":2620,"featured_media":10437,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"twitterCardType":"summary_large_image","cardImageID":0,"cardImage":"","cardTitle":"","cardDesc":"","cardImageAlt":"","cardPlayer":"","cardPlayerWidth":0,"cardPlayerHeight":0,"cardPlayerStream":"","cardPlayerCodec":"","footnotes":""},"categories":[703,657],"tags":[4877,4695,12346,11745,12350,12340,12338,10686,12344,12348,12342],"class_list":["post-10435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-radio-ingles","category-entrevistas-ingles","tag-biomarker","tag-biomarkers-en","tag-biomarkers-in-transplantation","tag-germany","tag-lc-msms-en","tag-michael-oellerich","tag-personalized-immunosuppression","tag-proteomics","tag-therapeutic-drug-monitoring","tag-transplantation","tag-waspalm"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/10435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/users\/2620"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/comments?post=10435"}],"version-history":[{"count":3,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/10435\/revisions"}],"predecessor-version":[{"id":10769,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/10435\/revisions\/10769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/media\/10437"}],"wp:attachment":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/media?parent=10435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/categories?post=10435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/tags?post=10435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}